Stay updated on Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer/update label was refreshed from Revision v3.5.2 to Revision v3.5.3, indicating a minor ClinicalTrials.gov site release rather than a change to the study record.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check44 days agoChange DetectedCore study details and eligibility criteria appear unchanged; only minor visual layout differences are visible.SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision indicator updated to v3.4.2, replacing v3.4.1. No substantive content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Ruxolitinib Cream PK in Atopic Dermatitis Clinical Trial page.